Attenuation of peripheral salt taste responses and local immune function contralateral to gustatory nerve injury: effects of aldosterone.
Dietary sodium restriction coupled with axotomy of the rat chorda tympani nerve (CTX) results in selectively attenuated taste responses to sodium salts in the contralateral, intact chorda tympani nerve. Converging evidence indicates that sodium deficiency also diminishes the activated macrophage response to injury on both the sectioned and contralateral, intact sides of the tongue. Because a sodium-restricted diet causes a robust increase in circulating aldosterone, we tested the hypothesis that changes in neurophysiological and immune responses contralateral to the CTX could be mimicked by aldosterone administration instead of the low-sodium diet. Taste responses in rats with CTX and supplemental aldosterone for 4-6 days were similar to rats with CTX and dietary sodium restriction. Responses to sodium salts were as much as 50% lower compared with sham-operated and vehicle-supplemented rats. The group-related functional differences were eliminated with lingual application of amiloride, suggesting that a major transduction pathway affected was through epithelial sodium channels. Consistent with the functional results, few macrophages were observed on either side of the tongue in rats with CTX and aldosterone. In contrast, macrophages were elevated on both sides of the tongue in rats with CTX and the vehicle. These results show that sodium deficiency or administration of aldosterone suppresses the immune response to neural injury, resulting in attenuation of peripheral gustatory function. They also show a potential key link among downstream consequences of sodium imbalance, taste function, and immune activity.
Guagliardo
Nick A
NA
Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22904, USA.
West
Katie Nicole
KN
McCluskey
Lynnette P
LP
Hill
David L
DL
D000284:Administration, Oral; D000450:Aldosterone / Q000008:administration & dosage / Q000378:metabolism*; D000584:Amiloride / Q000008:administration & dosage; D000818:Animals; D019771:Axotomy; D001522:Behavior, Animal / Q000187:drug effects; D002814:Chorda Tympani Nerve / Q000187:drug effects / Q000378:metabolism* / Q000601:surgery; D004039:Diet, Sodium-Restricted; D004305:Dose-Response Relationship, Drug; D005071:Evoked Potentials; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D015918:Infusion Pumps, Implantable; D007274:Injections, Intraperitoneal; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D023421:Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D026941:Sodium Channel Blockers / Q000008:administration & dosage; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage / Q000378:metabolism*; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000008:administration & dosage; D013649:Taste; D055697:Taste Perception / Q000187:drug effects; D013997:Time Factors; D014059:Tongue / Q000276:immunology / Q000294:innervation*
D026941:Sodium Channel Blockers; D017673:Sodium Chloride, Dietary; D049994:Sodium Potassium Chloride Symporter Inhibitors; D000450:Aldosterone; D000584:Amiloride; D005665:Furosemide
J Cardiovasc Pharmacol. 2006 Apr;47(4):609-13
16680076
Pflugers Arch. 2002 Jul;444(4):476-83
12136266
Hypertension. 2008 Feb;51(2):161-7
18172061
Trends Pharmacol Sci. 2008 Jul;29(7):367-74
18579222
Behav Neurosci. 1992 Aug;106(4):722-5
1323972
J Comp Neurol. 1977 Apr 15;172(4):627-46
838893
Immunology. 1985 Mar;54(3):589-99
3882559
Science. 1984 Jan 27;223(4634):403-5
6691151
J Physiol. 1987 Dec;393:413-24
3446802
J Neurosci. 1994 May;14(5 Pt 1):2904-10
8182447
J Comp Neurol. 2008 Aug 20;509(6):594-607
18546275
Am J Pathol. 2002 Nov;161(5):1773-81
12414524
J Comp Neurol. 1977 Apr 15;172(4):609-26
838892
Am J Physiol. 1985 Jan;248(1 Pt 2):R1-11
3881982
J Neurosci. 2002 Oct 1;22(19):8607-13
12351734
Am J Physiol. 1985 Jul;249(1 Pt 2):R52-61
2409823
J Gen Physiol. 1979 May;73(5):569-94
458420
Am J Physiol. 1996 Oct;271(4 Pt 2):R857-62
8897974
J Clin Invest. 1974 Jul;54(1):34-42
4365595
J Comp Neurol. 1999 Mar 15;405(3):406-20
10076935
J Lab Clin Med. 1976 Oct;88(4):571-7
135037
Comp Biochem Physiol Comp Physiol. 1992 Oct;103(2):269-73
1359950
Am J Physiol. 1996 Aug;271(2 Pt 1):C605-11
8770001
J Membr Biol. 1982;64(1-2):91-102
6276550
Brain Res. 1987 Mar 3;405(1):192-5
3567593
J Mol Endocrinol. 2009 Jun;42(6):449-59
19158233
Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1802-10
12384457
Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1754-61
18843094
Am J Physiol. 1980 Apr;238(4):F261-8
7377298
Ann N Y Acad Sci. 1981;372:64-78
6280560
Chem Senses. 2008 Feb;33(2):125-35
17962227
Acta Physiol Scand. 1970 May;79(1):88-94
5464393
Proc Natl Acad Sci U S A. 1978 Feb;75(2):975-9
204942
Physiol Behav. 2001 Apr;72(5):743-9
11337007
Clin Sci (Lond). 2002 Aug;103 Suppl 48:25S-30S
12193048
Behav Neurosci. 1986 Jun;100(3):390-8
3730147
J Neurophysiol. 1993 Jul;70(1):167-78
8395573
J Comp Neurol. 2004 Nov 1;479(1):43-55
15389612
J Physiol. 1967 Feb;188(3):353-71
6040583
J Biol Chem. 1992 Aug 15;267(23):16061-5
1379590
J Neurosci Res. 2007 Feb 1;85(2):364-72
17131425
J Neurosci Res. 2005 Apr 1;80(1):75-84
15742361
Physiol Rev. 1985 Oct;65(4):833-903
2414790
Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1275-84
12376422
Trends Neurosci. 1990 May;13(5):188-95
1693238